Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy [2]

AIDS

Volumn 12, Issue 1, 1998, Pages 110-112

  Deminie, C A ^a   Bechtold, C M ^a   Riccardi, K ^a   Rose, R E ^a   Samanta, H ^a   Lin, P F ^a   Colonno, R J ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; STAVUDINE;

ANTIVIRAL ACTIVITY; CLINICAL ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; PRIORITY JOURNAL;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CELLS, CULTURED; DNA, VIRAL; DRUG RESISTANCE, MICROBIAL; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; STAVUDINE;

EID: 0031982825     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (15)